177 related articles for article (PubMed ID: 8287615)
41. Characterization of an endogenous metalloproteinase in human vitreous.
Brown D; Hamdi H; Bahri S; Kenney MC
Curr Eye Res; 1994 Sep; 13(9):639-47. PubMed ID: 7805394
[TBL] [Abstract][Full Text] [Related]
42. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
43. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
[TBL] [Abstract][Full Text] [Related]
44. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 modulates the expression of gelatinase A and B in monocytic cells.
Kalebic T; Masiero L; Onisto M; Garbisa S
Biochem Biophys Res Commun; 1994 Dec; 205(2):1243-9. PubMed ID: 7802656
[TBL] [Abstract][Full Text] [Related]
46. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
47. Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B; Deryugina E; Leng J; Marchenko G; Dembrow D; Strongin A
Anal Biochem; 2000 Nov; 286(1):149-55. PubMed ID: 11038285
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
Ara T; Fukuzawa M; Kusafuka T; Komoto Y; Oue T; Inoue M; Okada A
J Pediatr Surg; 1998 Aug; 33(8):1272-8. PubMed ID: 9722003
[TBL] [Abstract][Full Text] [Related]
49. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
50. Gelatinolytic and type IV collagenolytic activity in bronchiectasis.
Sepper R; Konttinen YT; Sorsa T; Koski H
Chest; 1994 Oct; 106(4):1129-33. PubMed ID: 7924484
[TBL] [Abstract][Full Text] [Related]
51. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
Young TN; Rodriguez GC; Rinehart AR; Bast RC; Pizzo SV; Stack MS
Gynecol Oncol; 1996 Jul; 62(1):89-99. PubMed ID: 8690299
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Hietanen J; Sorsa T
J Oral Pathol Med; 1995 Feb; 24(2):78-84. PubMed ID: 7745546
[TBL] [Abstract][Full Text] [Related]
53. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
54. Characterization of matrix metalloproteinases in human urine: alterations during adolescence.
Thrailkill KM; Kumar S; Rosenberg CK; Auten KJ; Fowlkes JL
Pediatr Nephrol; 1999 Apr; 13(3):223-9. PubMed ID: 10353410
[TBL] [Abstract][Full Text] [Related]
55. A versatile assay for gelatinases using succinylated gelatin.
Baragi VM; Shaw BJ; Renkiewicz RR; Kuipers PJ; Welgus HG; Mathrubutham M; Cohen JR; Rao SK
Matrix Biol; 2000 Jul; 19(3):267-73. PubMed ID: 10936451
[TBL] [Abstract][Full Text] [Related]
56. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
57. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia.
Clark AW; Krekoski CA; Bou SS; Chapman KR; Edwards DR
Neurosci Lett; 1997 Nov; 238(1-2):53-6. PubMed ID: 9464653
[TBL] [Abstract][Full Text] [Related]
58. Gelatinase activity in keloids and hypertrophic scars.
Neely AN; Clendening CE; Gardner J; Greenhalgh DG; Warden GD
Wound Repair Regen; 1999; 7(3):166-71. PubMed ID: 10417752
[TBL] [Abstract][Full Text] [Related]
59. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
60. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva.
Golub LM; Sorsa T; Lee HM; Ciancio S; Sorbi D; Ramamurthy NS; Gruber B; Salo T; Konttinen YT
J Clin Periodontol; 1995 Feb; 22(2):100-9. PubMed ID: 7775665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
